Antibody-drug conjugates (ADCs), which combine monoclonal antibodies with cytotoxic agents, offer a targeted approach to cancer therapy, aiming to deliver ...

State lawmakers are pushing a bill to ban food additives that have been linked to cancer and behavioral issues, but there is ...

Through this study, we aim to offer a new, innovative treatment to patients,” medical oncologist Dr. John Lenehan said.

Some popular synthetic hair products used for braids, twists and extensions may contain cancer-causing chemicals and high ...

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the ...

The firm's E1000 Dx Digital Pathology Solution consists of an automated scanner, whole-slide image viewer, and image management and viewing software.

A blood test that detects tiny fragments shed by bowel cancer cells could help catch the disease at its earliest stage, ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on ...

The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood cancer patients, caregivers, healthcare ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

BeiGene (ONC) has received FDA approval for Tevimbra for first-line esophageal cancer with chemo. Read more here.